Product Information
FENOFIBRATE 48 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0839 per EA under NDC 69097045905. Its NADAC has been published 485 times since Mar 15, 2017.
Strength
48 mg/1
Manufacturer
Cipla USA Inc.NDC
69097045905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208709On Market Since
12/15/2016
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 48 MG TABLET has been published 485 times since Mar 15, 2017, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0839 per EA |
|---|---|
| All-time high | $0.4370 (May 10, 2017) |
| All-time low | $0.0822 (Feb 18, 2026) |
| 52-week high | $0.1028 |
| 52-week low | $0.0822 |
| Median price | $0.1237 |
| Average price | $0.1663 |
| Largest weekly change | -23.1% (Apr 17, 2024) |
| Weeks tracked | 485 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the FENOFIBRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FENOFIBRATE 48 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 48 MG TABLET, manufactured by Cipla USA Inc., is $0.0839 per EA (NDC 69097045905), effective Jun 24, 2026.
How has the price of FENOFIBRATE 48 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 48 MG TABLET has declined 80.0%. It has been tracked across 485 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 48 MG TABLET?
Since Mar 15, 2017, the NADAC for FENOFIBRATE 48 MG TABLET has ranged from a low of $0.0822 (Feb 18, 2026) to a high of $0.4370 (May 10, 2017), with a median of $0.1237 per EA.
Are there cheaper alternatives to FENOFIBRATE 48 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FENOFIBRATE 48 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures FENOFIBRATE 48 MG TABLET?
FENOFIBRATE 48 MG TABLET (NDC 69097045905) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification